Kihealth Labs leadership walking through a modern molecular diagnostics laboratory

Leadership Driven by Science. United by Purpose.

Kihealth Labs brings together leaders in molecular diagnostics, laboratory medicine, clinical research, and biotechnology to advance a new generation of precision metabolic diagnostics — designed to detect disease earlier and enable smarter intervention.

Contact our team

Executive Team

The people driving precision diagnostics forward.

Chief Executive Officer & Co-Founder

Jenna Anderson

Jenna Anderson is the Co-Founder and Chief Executive Officer of Kihealth, where she leads the company's strategy, commercialization, fundraising, and growth initiatives. With more than two decades of experience spanning healthcare, biotechnology, digital health, and consumer wellness, Jenna has built and scaled innovative organizations at the intersection of science and technology. Prior to Kihealth, she held executive leadership positions with AccessElite, Concierge Key Health, ALPHAEON Corporation, and Allergan.

Strategic VisionGrowth LeadershipInvestor Relations

Jenna@kihealth.com

Chief Operations Officer & Co-Founder

Robert E. Mons III

Robert E. Mons III is the Co-Founder and Chief Operations Officer of Kihealth, where he oversees operations, business development, strategic partnerships, government affairs, and corporate growth. Robert spent six years in the United States Congress and held senior leadership roles in Florida state government, bringing deep experience in healthcare policy, public affairs, and regulatory strategy.

OperationsPublic AffairsRegulatory Strategy

Robert@kihealth.com

Chief Medical Officer

Dr. Matthew R. Benson, MD

Dr. Matthew Benson is a board-certified pediatric endocrinologist and nationally recognized diabetes specialist. He serves as Medical Director of the Northeast Florida Pediatric Diabetes Center at Nemours Children's Health and provides clinical leadership across research, regulatory strategy, physician engagement, and product development for Kihealth.

Board CertifiedClinical StrategyTranslational Research

Matthew@kihealth.com

Chief Scientific Officer

Dr. Clifford Morris, PhD

Dr. Clifford Morris is a molecular biologist and diagnostics innovator with extensive experience in biomarker discovery, translational research, assay development, and precision medicine. He leads scientific strategy, research collaborations, and platform expansion across Kihealth's molecular diagnostics portfolio.

PhDBiomarker DiscoveryAssay Development

Clifford@kihealth.com

Laboratory Director

Dr. Ioan Cucoranu, MD, FCAP

Dr. Ioan Cucoranu is an accomplished laboratory physician and molecular diagnostician. As Laboratory Director, he oversees clinical laboratory operations, quality systems, assay implementation, and regulatory compliance — ensuring the highest standards of scientific rigor and analytical performance.

MD, FCAPCLIA CertifiedMolecular Pathology

Ioan@kihealth.com

Vice President, Research & Development

Marshall Jaroch

Marshall Jaroch leads research and development at Kihealth and plays a critical role in assay development, analytical validation, platform optimization, and translational research — bridging scientific innovation with real-world clinical application.

R&D LeadershipValidationMethodology

Marshall@kihealth.com

Our Guiding Principles

The values that shape every program we build.

Rooted in scientific rigor and clinical excellence, these core values define how we pursue molecular diagnostics and disease interception at scale.

Scientific Integrity

Every decision we make is grounded in rigorous, reproducible molecular science. We prioritize analytical validity, peer-reviewed evidence, and transparent data practices so that every claim we publish can withstand clinical scrutiny.

Uncompromising Integrity

We hold ourselves to the highest standards of ethics, transparency, and quality. From regulatory compliance to patient communication, we operate with the accountability that diagnostic medicine demands.

Collaborative Excellence

We work shoulder-to-shoulder with clinicians, researchers, academic institutions, and industry partners. Breakthrough diagnostics are built through shared expertise, not isolated effort.

Translational Innovation

We translate breakthrough biology into practical clinical tools. Our platform moves from scientific insight to validated assay to real-world care, closing the gap between discovery and impact.

Patient-Centered Care

Patients sit at the center of every program we build. We design diagnostics that reduce uncertainty, accelerate intervention, and preserve quality of life for individuals and families affected by metabolic disease.

Evidence-Based Medicine

Peer-reviewed evidence anchors our claims, our assays, and our roadmap. We invest in clinical validation, publish our findings, and let the data guide our path to commercialization.

Scientific & Clinical Advisors

A standing council of field-defining scientists.

Our advisors guide program data review, biomarker discovery, and clinical study design — bringing world-class expertise across diabetes, endocrinology, cell transplantation, and biotech strategy.

Eitan Akirav, PhD

Scientific Advisor

Director of Business Development, Harvard University

Dual focus on scientific innovation and biotech business strategy.

Dr. Camillo Ricordi

Scientific Advisor

Director Emeritus, Diabetes Research Institute, University of Miami

Internationally renowned physician-scientist and pioneer in diabetes research, regenerative medicine, and cellular transplantation.

Dr. Kevan Herold

Scientific Advisor

Professor of Immunobiology & Medicine, Yale School of Medicine

World-leading expert in Type 1 diabetes prevention and immunotherapy; central to the development of teplizumab.

Dr. Larry Fox

Clinical Advisor

Chief of Pediatric Endocrinology, Nemours Children's Health

34+ years in pediatric endocrinology, clinical research, and integration of novel diagnostics into care.

Dr. Shadi Abdelnour

Clinical Advisor

Endocrinologist, Cedars-Sinai Medical Center

Board-certified endocrinologist combining evidence-based care with advances in precision metabolic medicine.

Board of Directors

Independent oversight. Operator pedigree.

Kihealth's board pairs deep capital-markets discipline with operators who have scaled category-defining companies — guiding strategy, governance, and long-horizon value creation.

Chairman of the Board

Scott A. Blum

Founder, ThinkTank Holdings · Founder, Buy.com

Visionary entrepreneur and founder of ThinkTank Holdings LLC, a private investment firm focused on technology, commerce, and media. Founder of Buy.com — one of the earliest and most successful e-commerce platforms — with deep expertise scaling category-defining ventures.

ScalingCapital StrategyDisruption

Board Member

Parker Kelley, CPA

Kramer-Wilson Company · fmr. CFO, KW Specialty Insurance

Seasoned financial strategist and California CPA with a career spanning corporate finance, public accounting, and investment management. Founding CFO of KW Specialty Insurance, where he built the company to a $101M statutory surplus and an A.M. Best A- (Excellent) rating.

Fiscal StrategyOperationsInvestment Structuring

Board Member

Cameron Gray, PhD, JD

Founder & CEO, Alcedo Capital · fmr. MD, MDB Capital Group

Distinguished biotechnology and investment leader. PhD in Biophysics (University of Virginia), JD (George Washington University Law School). Previously Managing Director at MDB Capital Group funding disruptive technology companies.

BiotechCapital MarketsIP Strategy

Kihealth Labs scientific team collaborating in the laboratory

Our Culture

Building More Than a Company

Kihealth Labs is built on scientific curiosity, translational research, and a collaborative culture that connects molecular scientists, clinicians, and academic partners. We pursue clinical excellence with mission-driven innovation — focused on detecting disease earlier and improving outcomes at scale.

Scientific curiosity
Translational research
Collaborative culture
Academic partnerships
Clinical excellence
Mission-driven innovation

Join Us in Building the Future of Metabolic Diagnostics

Whether you are a scientist, physician, partner, or investor — we'd love to hear from you.

Research Partnerships Provider Partnerships Contact Leadership